In this episode of the Ageless Future Podcast, Cade Archibald discusses emerging research surrounding MUSE (Multilineage-Differentiating Stress-Enduring) cells and their growing role in regenerative medicine. The conversation explores why researchers are studying these cells, including their resilience, ability to adapt to different tissue environments, and potential applications being investigated across areas such as neurological, cardiovascular, and immune-system research. Cade highlights the broader vision of longevity science, emphasizing the importance of recovery, resilience, personalized health strategies, and data-driven approaches to maintaining function as people age. The episode concludes with practical lifestyle reminders focused on sleep, movement, nutrition, and daily habits that support long-term wellness and healthy aging. RESOURCES: Book Comprehensive Labs: https://agelessfuture.com/longevity-labs/ FREE copy of The Peptide Blueprint: https://agelessfuture.com/blueprint Sign up for future Health Accelerator Challenges calls LIVE! https://us02web.zoom.us/webinar/register/WN_YZsiUMOzSyqcE8IinC5YEQ#/registration Books: https://www.amazon.com/Books-Regan-Archibald/s?rh=n%3A283155%2Cp_27%3ARegan%2BArchibald Articles: https://medium.com/search?q=Regan+Archibald LIKE/FOLLOW/SUBSCRIBE: YouTube -https://www.youtube.com/@ReganArchibald / https://www.youtube.com/@Ageless.Future LinkedIn: https://www.linkedin.com/in/regan-archibald-ab70b813 Instagram: https://www.instagram.com/ageless.future/ Facebook: https://www.facebook.com/AgelessFutureHealth/ DISCLAIMER: This video is for educational purposes only and does not provide medical advice, diagnosis, or treatment. Many of the molecules discussed in this video are research compounds and are not approved by the U.S. Food and Drug Administration (FDA) for any specific medical use, indication, or condition. They are mentioned only in the context of existing scientific literature and ongoing research and are not being recommended, prescribed, sold, or offered through this video. This content does not endorse or recommend any specific tests, products, procedures, or treatment protocols.References to our clinic are for general educational context only; investigational or non‑approved products are not available for direct ordering or prescribing based solely on viewing this content. Do not start, stop, or change any medication, peptide, or supplement based on this video. All medical decisions must be made with a licensed prescribing clinician after a proper evaluation. No provider-patient relationship is created by viewing this content or contacting our clinic. Regan Archibald is a Licensed Acupuncturist and longevity coach. He is not a medical doctor. Cade Archibald is COO and Co-Founder of Ageless Future, also not a medical doctor. All medical decisions, lab ordering, and prescribing in our clinic are performed only by our licensed medical team (MD, APRN, PA). Viewers should follow the guidance of their own licensed clinicians and local health authorities regarding diagnosis and treatment decisions.
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
Speaker 1Researchers are.
Speaker 2They're describing these muse cells as one of the most intriguing discoveries in regenerative medicine over the past decade. Rather than forcing the body to repair itself, these scientists are interested in understanding how these cells may work alongside the body's natural recovery systems. I remember growing up it's like, if you can never get back brain cells, you know, don't hold your breath too long, or don't do this, or don't get traumatic brain intrigues. And we've discovered that's not necessarily the case.
Speaker 1Your brain can regenerate, but it's very difficult.
Speaker 2It's very limited natural repair capacity compared to other tissues in the body. The sky's the limits. It's when we kind of sit back and let a disease or a diagnosis put a label on us and use that as you know what, as an identity, and those things are what we've seen historically really create a downward spiral. We have the data we're testing over and over. It's almost like that the future of personalized regenitative medicine is here
Speaker 2right now at Ageless Future.
Speaker 1Welcome everybody to the.
Speaker 2Ageless Future podcast. This is your host today Kate Archibald, We're gonna continue on the same same pathway that we've been working on with some of the regenerative medicines, stem cells, specifically MEW cells, and some of the most latest and greatest research around new cells. So I'm excited to dive in today.
Speaker 1Think about this.
Speaker 2We have this next frontier in regenerative medicine. Regenera medicine has been around for a few years. It's you know, it's still relatively new, but there's just more and more coming out with regenerative medicine.
Speaker 1And you know.
Speaker 2We're seeing why researchers are watching U cells so closely, just a lot of really really cool dynamics there.
Speaker 1And so.
Speaker 2What what makes these mu cells different and and how they're they're so dynamic is you know, and and a lot of different cell therapies they focus on delivering cells into the body and just hoping they'll survive. But what what we're seeing U cells appear to be different where you know, they can They've been observed a lot of
Speaker 2different characteristics that make it you know, seems like the ability for them to outstand a lot of the environment inside the human body. They can withstand a lot more and potentially have a lot more therapeutic effects. So they've observed, you know, they naturally migrate towards injured tissue, and we've seen this with with just traditional umbilical cord tissue stem cells.
Speaker 2But what we're seeing with muse cells is that concentration is a lot more consistent, and so you're getting you know, with with like what those mus cells in on if you take just a traditional vial of stem cells, is you know, you'll have mus cells in there. And those are the most potent and powerful, most robust cells discovered in Japan, as we've we've talked previously, and they're able
Speaker 2to handle a lot more stress and they're more resilient than some of those some of the other cells or stem cells in there. And so now we've we've worked with a lab to kind of condense those and just focus on the MU cells rather than you know, the whole profile, which you know, the whole profile very very effective with protein CETO kinds. The amino acid change that you get from that of bilical cord birth tissue, even
Speaker 2without the live stem cells, can be just therapeutic in and of itself. But now you're getting that along with just concentrated muse cells, and you know, theoretically could be completely game changing from a clinical application, we're starting to see that where you know, non responders are getting responses from these muse cells versus you know, what they've done in the past. But I'm gonna talk of getting off
Speaker 2on a tangent here. We're going to focus on this kind of researchers what what they're looking at. They're they're studying this kind of natural repair oriented behavior, the unique biology like they're they're starting to get a lot more global interest.
Speaker 1You know.
Speaker 2They they appear to be capable of surviving very stressful environments, they can integrate into different tissue environments, they seem to interact with the immune system differently than other cell types, and so, you know, because of these these traits, researchers are they're they're describing these mute cells as one of the most intriguing discoveries in regenerative medicine over the past decade. Uh And so, rather than forcing the body to repair itself,
Speaker 2these scientists are interested in understanding how these cells may work along the body's natural recovery systems. And that's what I think is really fascinating if you look at you know, the these the research behind us is, you know, really you're having all these scientists and researchers really dive in because the possibilities seem, you know, very very promising. And you know, we've started, you know, taking taking this on
Speaker 2from a clinical standpoint on more of a much much smaller scale, but seeing seeing phenomenal outcomes there as well. But let's let's talk about the potential advantage on the immune immune tolerance side of things. So, you know, one one of the major challenges in regenitive medicine historically has been this thought process of immune rejection. So you know, if especially if you're you're you know, infusing or injecting
Speaker 2certain cell types, there's always risk of immune rejection. Where we haven't necessarily experienced that with the specific stem cells in you know, with umbilical cord tissue where they haven't been been shown a specific lineage yet. But when you get into more manipulated stem cells and you know, specific cells for particular line cell lineages, so if they've been
Speaker 2kind of transformed to be more chondrocites or heart cells or brain cells things like that, it's where there's there's little very much higher risk of immune rejection where you know, if you look at mute cells, they appear to be you know, unusually well tolerated in these research settings as far as being able to be dynamic and not have that same risk factor of immune rejection. And they're dynamic enough where they're able to follow those lineages, so you know,
Speaker 2really may simplify that kind of future potential therapeutic applications. So another thing that researchers are heavily investigating and researching is IV delivery. So you know, and I think that you know, if you think about innravenous delivery or some form of systemic effect is always you know, I've I've
Speaker 2talked to a lot of clients and patients over the years about different stem cell applications and things, and I think everyone asks, you know, can I just get an IV and we'll let, you know, fix my back pain and fix every problem in my body, And it's typically not the case.
Speaker 1What what these ivs are.
Speaker 2Doing is they're more focused on the internal organs and system in the body versus you know, you have direct injections for or like if you have isolated injuries. We want to get a higher concentration into that area. But what's so fascinating is we we've seen this natural homing behavior. And you know, and I wish I had the diagram here, I've I've showed it in the past, but there's a
Speaker 2study done where they radio tagged stem cells in this ivy administered it through the left hand, you know, just through a vein there pushed stem cells. And this person had right hand arthritis and a few other things, and so they took it a scan immediately after the procedure and you could actually see where the stem cells had migrated based on those radio tags, and you saw a
Speaker 2clump in that right hand where there was arthritis. There was a lot in the internal organs, lungs, liver, and a little in the thyroid. And what was interesting is this person also had some diabetes and thyroid issues, and so you know, I saw it in the pancreas, liver, thyroid, some of the lungs, and then right hand arthritis. Took another scan ninety days later and you could still see
Speaker 2the clump in the right hand and there was still remnants of those cells in those particular areas.
Speaker 1So showing that they home in on.
Speaker 2Areas of you know, whether it's damage tissue or immune compromise to issue, and you know, really really interesting on the homing side if you look at it from you cells in the brain, a lot of interesting neurological uh impacts there. So if you think about it, the brain, and historically, like I remember growing up, it was like if you know you can never get back brain cells,
Speaker 2you know, don't don't hold your breath too long, or don't do this, don't do that, or don't get traumatic brain injuries. And we've discovered that's not necessarily the case. Your brain can regenerate, but it's very difficult. It's very limited natural repair capacity compared to other tissues in the body. And so the brain's always a very exciting place of research just because of the possibilities like if if we can keep our brains online and cognitive of and thinking
Speaker 2and processing remembering things appropriately. You know that in our mind, Like, the brain is one of the biggest pillars when it comes to longevity, because if you lose your cognitive abilities, it doesn't matter how healthy the rest of your body is. It kind of all goes to waste. Versus if you you've got a brilliant mind and a brilliant brain, you can function there usually we can.
Speaker 1We can work on the other areas as well.
Speaker 2Obviously you've got to have a good healthy heart, good good muscle. You know, there's there's all these other components. But man, the brain is critical for long term longevity, and so really interested in uh, these scientists are exploring how these cells interact with nerve tissues and looking at brain recovery on you know, with these muse cells, and so you're seeing different studies in these models on how
Speaker 2it can affect with strokes, brain injuries like TBIs, nervous system damage, neurodegenerative conditions like MS Parkinson's, those neurodegenerative conditions that can be devastating.
Speaker 1And so if you know these muse.
Speaker 2Cells have you know, the researchers are thinking, hey, these may have the potential to reverse some of these conditions. We've seen it clinically be extremely helpful and a lot of different conditions. But I wouldn't necessarily say like, hey, this is the you know, panacea of the cure. But what it does is it can go in and help with repairing some of the damage, reduce some of that
Speaker 2inflammation that that fire in the brain and that gives the ability to get back to some somewhat of a normal function, you know. And then the other piece, so talked about the brain, what about the heart and cardiovascular research and so seeing some some very interesting things there because you know, just like the brain, the heart muscle
Speaker 2and heart tissue once it's damaged, it's very difficult to recover and repair heart tissue.
Speaker 1And so you know, these researchers are.
Speaker 2Exploring how MEW cells behaving cardiovascular environments and whether they can mitigate towards injured tissues. So they're they're researching and looking at how that tissue signaling is it's happening the inflammation, right elation, what kind of cellular integration, meaning how those cells come in and actually can turn and turn on
Speaker 2and regenerate heart cells, and then what are the recovery support mechanisms. So very very interesting on mute cells with the heart, and another very widely seen UH condition would be in autoimmunity and in different inflammatory conditions. That's this is where.
Speaker 1We're getting more and more.
Speaker 2You know, understanding of immune communication. But the interesting thing with mute cells and being able to handle these inflammatory environments and having high tolerance and what they're able to to do to help help with with kind of clearing up uh, immune compromised individuals. So, you know, if the immune systems just that immune intelligence is reduced, maybe is
Speaker 2there's some ways that these stem cells can improve intelligence.
Speaker 1They're studying.
Speaker 2Autoimmune and inflammatory conditions, interested in how these cells interact with immune signaling pathways. Doesn't necessarily mean that immune cells or the solution to autoimmune conditions or diseases, but you know, they're they're looking at some really important questions of how do these cells communicate with with immune cells, why do they appear to tolerate you certain environments, and what can
Speaker 2they teach us about inflammatory recovery and then just understanding the overall immune communication. If if we can get that information better, we're gonna These researchers believe they they have more and more data and so, you know, from a clinical standpoint, we've we've seen, you know, there's a few things that we can measure when we've used these cells
Speaker 2with these treatments with someone with say an autoimmune condition or or different things. Is we've we've had clients with autoimmunity or our thyroid antibodies. We've we've seen homo systeine levels elevated or a lot of inflammatory UH markers elevated, and we're seeing, you know, from a clinical standpoint, and I'm you know, you could say it's a correlation rather
Speaker 2than causation, because right now I'm on a recording published on YouTube, and I don't necessarily want to say there's there's any any specific condition or disease that we're treating. But if you look at the measure of the results, it's pretty intriguing and telling. When you see antibodies reduced, when you see you know, inflammatory markers chains and shift, I'm pretty pretty telling and exciting to see that. You know, we're heading in the right direction. We have just some
Speaker 2some fascinating solutions here or potential solutions. So some of the clinical trials I'm happening here, there's UH human clinical research involving new cells. More and more we're seeing if you look at a PubMed or I just met with a new research group today that will help validate.
Speaker 1Certain research studies.
Speaker 2So I I'm excited to use some of that research for our future Ageless Future podcasts.
Speaker 1But and the the data that we're seeing in.
Speaker 2Stem cells and specifically I muse cells. Just fascinating to see all the more and more data coming out on how how we can have better safety profiles. You know, how how this tissue targetings work, different immune reactions, recovery outcomes, and so you have you know, scientists in the lab working and seeing how things interact in a laboratory setting.
Speaker 2You also will see it in isom rats. And now we're starting to see some some unique different you know, human human studies. For us at the clinical place, we're not necessarily treating speci of diseases or conditions, so we wouldn't qualify as you know, clinical trial. But you know we're we're working potentially working with some groups to join there. But overall from a longevity and health resilience standpoint, like
Speaker 2the downsides haven't found many or any, but and the upside and potential significant, significant possibilities. And you know that that leads us into what what this could mean for longevity science because you know, we're we're looking at how how can we preserve function and recovering, resilience and adapting
Speaker 2to changes, especially like talking about the brain, the heart, the muscles, how those age can really.
Speaker 1Impact how how you know you you how.
Speaker 2Your longevity expectations are, and so some very very exciting things there. And then you look at the future personalized regenerative medicine and how reviewing some of these biomarkers and advanced testing can really help shape the direction and the right protocol and process. And essentially that's that's why we applied for our patent on our our Ageless Future operating system.
Speaker 1Is you know, you think about if we can.
Speaker 2Get all the right tools and ingredients for someone's future and then roadmap that out based on the right the right diagnostics and then the right protocol, and then we have the data that we're testing over and over and seeing seeing amazing outcomes. And yeah, it's it's it's almost like that that the future of personalized regenitive medicine is
Speaker 2here right now at Ageless Future. I think the rest of medicine may you know, some some are catching up, some are there, but man, we'd love being on the forefront of that. And so, you know, if you look at the bigger picture, are the vision the goal building a resilient human system where you have longevity research, you know, really focus on recovery and resilience. You have the cellular repair systems that are becoming very very research heavy as well,
Speaker 2like recovering these I think I recorded a podcast a couple of weeks ago with with a doctor that is his his vision and his goal is no knee replacements after I think it's twenty thirty two. I can't remember the exact date. You guys are going to fact check me on that, and I'm going.
Speaker 1To get it wrong.
Speaker 2But the point being is we have the regenerative medicine features. We also have the lifestyle interventions and different peptides to help eliminate unnecessary surgeries or these these barbaric surgeries where you can have more regeneration and recovery. Obviously, there's always going to be need for surgeries, and if there's a big.
Speaker 1Accidents, that can happen.
Speaker 2But if we can have ways to reduce how our bodies break down and you know, knee replacements from arthritis, arthritis is something that we should be able to hedge because if we can get ahead of that and someone's you know, twenties and thirties and have them recovering faster and better and enhancing their resilience, arthritis will take a lot longer time to form and maybe potentially we we reduce or eliminate that completely. And that's that's obviously a
Speaker 2vision and a concept, but you know that that's one of his uh doctor p Is vision. So yeah, the future is really emphasizing on maintaining function rather than reacting to decline, and not not even maintaining but enhancing and continually improving and moving forward. And I think that's that's what our stance at Ageless Future is is if you always have a bigger future, you're always looking at that
Speaker 2like what's what's next from a health perspective, and you're always growing there. Man, the sky's the limit. It's it's when we kind of sit back and let a disease or a diagnosis put a label on us and and use that as you know, what what as an identity and and those things are or what we've seen historically really create you know, a downward spiral. And so if
Speaker 2we keep moving, we keep measuring and watching and always progressing, it's really exciting and intriguing to see where things will go from there.
Speaker 1And so.
Speaker 2Yeah, I want to issue guys a challenge this week, so prioritize your sleep, movement, and recovery every day so you can use this. So if you kind of follow our six essentials, let's let's just start with sleep, so we can get eight hours of sleep daily and then movement. Thirty thirty is kind of the general rules, So thirty minutes of like high intensity exercise, thirty minutes of outdoor
Speaker 2activity or exercise, So go mountain bike and go for a walk or a run, or pickleball or skiing, whatever it is. Get outside, get in the air, get at least thirty minutes there, thirty minutes exercise hour total, get your sleep, and feel amazing. Do what you can. You control what you can control. Can't control all the variables coming at you. But if you can make some decisions
Speaker 2right now of how I'm going to sleep, how I'm going to move, and then what I put into my body, and you know, just eliminate anything that's processed or that's going to diminish your health. So that's going to be like your process, junk, lots of sugar, artificial anything.
Speaker 1Around those areas.
Speaker 2Kind of stay away from focus on real foods, real proteins, real real things. You're going to be headed in the right direction. So Hopefully you had a good time today. Appreciate you guys by joining me, and you have an amazing day.
Speaker 1And thank you Ken.
Speaker 2Loved this fantastic information and cheers to a bright and vibrant future. Love you all have an amazing day. I'll see you next week.
Can the way you think actually change how long, and how well, you live? In this episode of the Ageless Future Podcast, Regan Archibald sits down with Harvard-trained psychiatrist and brain researcher Dr. Srini Pillay to...
What if your body's most powerful repair signal is fading while you sleep? In this episode of the Ageless Future Podcast, Cade Archibald and Regan Archibald explore growth hormone, why it matters for muscle, recovery,...
In this episode of the Health Accelerator Challenge, Cade Archibald breaks down three numbers that can help predict how long you'll live, and how many of those years you'll stay strong, mobile, and independent. He...
What can an endurance athlete’s mindset teach us about entrepreneurship and leadership? In this episode of the Ageless Future Podcast, Regan Archibald talks with entrepreneur and coach Taylor Thomas about how years of...
What shapes the way you think about health, longevity, and the choices you make? In this episode of the Ageless Future Podcast, Cade Archibald sits down with entrepreneur, author, filmmaker, and chiropractor Dr. Patrick...